Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Synthego, a start-up that sells CRISPR gene-editing tool kits and CRISPR-edited cells to researchers, raised $110 million in series C financing last week from the venture capital firms Founders Fund, 8VC, and Menlo Ventures. The start-up is using automation and machine learning to quickly scale up the production of customized CRISPR kits and engineered cells. Chief Operating Officer Ted Tisch says Synthego’s goal is to help lower the cost of cell and gene therapies from hundreds of thousands of dollars to thousands of dollars.
This article has been sent to the following recipient: